London, United Kingdom - March 14, 2016, London, United Kingdom - Indivior, a specialty pharmaceuticals business, announced that Adrian Hennah will step down from the board and audit committee and not stand for re-appointment at the AGM on May 11, 2016.
Mr. Hennah was appointed as a non-executive director of Indivior in December 2014. He joined the Company in January 2013 as Chief Financial Officer Designate, and was appointed as CFO in February 2013.
He joined the Company following six years at Smith & Nephew plc, as CFO. Previously he was CFO for four years at Invensys, the international engineering company.
Mr. Hennah also spent 18 years at GlaxoSmithKline plc, one of the world’s largest pharmaceutical companies, holding a number of senior management and financial roles. ■